- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Emerging Immunotherapies for Parkinson Disease ; day:11 ; month:12 ; year:2018 ; pages:1-16
Neurology and Therapy ; (11.12.2018), 1-16
- Creator
-
Zella, Samis M. A.
Metzdorf, Judith
Ciftci, Emine
Ostendorf, Friederike
Muhlack, Siegfried
Gold, Ralf
Tönges, Lars
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-018-0122-z
- URN
-
urn:nbn:de:101:1-2019012715030687127792
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zella, Samis M. A.
- Metzdorf, Judith
- Ciftci, Emine
- Ostendorf, Friederike
- Muhlack, Siegfried
- Gold, Ralf
- Tönges, Lars
- SpringerLink (Online service)
Other Objects (12)
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Potentials and limitations of current and emerging immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Molecular imaging biomarkers for cell-based immunotherapies
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Potentials and limitations of current and emerging immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Molecular imaging biomarkers for cell-based immunotherapies
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Potentials and limitations of current and emerging immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Harnessing bioengineered myeloid progenitors for precision immunotherapies